• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Epidermal growth factor (EGF) binding to membranes immobilized in microtiter wells and estimation of EGF-related transforming growth factor activity.

作者信息

Kimball E S, Warren T C

出版信息

Biochim Biophys Acta. 1984 Mar 28;771(1):82-8. doi: 10.1016/0005-2736(84)90113-5.

DOI:10.1016/0005-2736(84)90113-5
PMID:6322847
Abstract

The binding of radiolabeled epidermal growth factor (EGF) to immobilized A-431 target cell membranes coupled to polyvinyl chloride microtiter wells is described. Saturation curves and Scatchard analysis of the data indicate that the observed binding parameters are consistent with those previously reported. Binding capacity of the membranes are approx. 6.6 pmol EGF per mg membrane protein. Kinetics of 125I-EGF binding were slower, however, than reported for binding to membranes in suspension, although binding constants were not greatly different. The high- and low-affinity binding constants for 125I-EGF were calculated to be approximately 1 X 10(12) M-1 and 2.5 X 10(9) M-1, respectively. Application of this technique in a competitive binding assay requires no more than 2.5 micrograms of membrane protein per assay, is essentially complete after 60 min, and facilitates screening of a large number of samples in a short time. Therefore, this will assist in the evaluation and quantitation of EGF and EGF-related transforming growth factor activity in physiological fluids. This technique may also be applied to analyses of other hormone-receptor systems.

摘要

相似文献

1
Epidermal growth factor (EGF) binding to membranes immobilized in microtiter wells and estimation of EGF-related transforming growth factor activity.
Biochim Biophys Acta. 1984 Mar 28;771(1):82-8. doi: 10.1016/0005-2736(84)90113-5.
2
Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells.表皮生长因子样转化生长因子。II. 与人胎盘膜和A431细胞中表皮生长因子受体的相互作用。
J Biol Chem. 1983 Nov 25;258(22):13614-20.
3
Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.一种不与表皮生长因子相互作用的转化生长因子受体的亲和标记
Proc Natl Acad Sci U S A. 1982 Nov;79(22):6822-6. doi: 10.1073/pnas.79.22.6822.
4
Expression of hepatic transforming growth factor receptors during late gestation in the fetal rat.胎鼠妊娠晚期肝脏转化生长因子受体的表达
Endocrinology. 1989 Dec;125(6):3037-43. doi: 10.1210/endo-125-6-3037.
5
Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.与正常个体相比,癌症患者尿液中转化生长因子活性的高效液相色谱图谱明显不同。
Cancer Res. 1984 Aug;44(8):3613-9.
6
Real-time kinetics of ligand/cell surface receptor interactions in living cells: binding of epidermal growth factor to the epidermal growth factor receptor.活细胞中配体/细胞表面受体相互作用的实时动力学:表皮生长因子与表皮生长因子受体的结合
Biochemistry. 2001 Aug 28;40(34):10230-42. doi: 10.1021/bi010705t.
7
Epidermal growth factor receptor number decreases during rat liver regeneration.大鼠肝脏再生过程中表皮生长因子受体数量减少。
J Clin Invest. 1981 May;67(5):1580-3. doi: 10.1172/jci110190.
8
Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.乳腺肿瘤活检中表皮生长因子结合情况及其与雌激素受体和孕激素受体水平的关系。
Cancer Res. 1984 Aug;44(8):3448-53.
9
Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity.表皮生长因子-受体-蛋白激酶相互作用。受体与表皮生长因子的共纯化增强了磷酸化活性。
J Biol Chem. 1980 May 25;255(10):4834-42.
10
Epidermal growth factor binding by membranes of human renal cell carcinomas: establishment of an epidermal growth factor receptor assay for clinical use.
Int J Urol. 1994 Dec;1(4):319-23. doi: 10.1111/j.1442-2042.1994.tb00057.x.